Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ-0,56
KB0,20
PKN148,1148,163,18
Msft389,81389,87-1,87
Nokia0,21
IBM275,37275,561,15
Mercedes-Benz Group AG47,4350,69
PFE26,2226,232,44
11.06.2026 21:51:44
Indexy online
AD Index online
select
AD Index online
 

  • 11.06.2026 18:00:00
Elekta AB (EKTAb.ST, Stockholm)
Poslední obchod Změna (%) Změna (SEK) Objem obchodů (SEK)
52,05 -1,70 -0,90 60 945 437
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 11.06.2026
Popis společnosti
Obecné informace
Název společnostiElekta AB (publ)
TickerEKTA B
Kmenové akcie:Ordinary Shares Class B
Kmenové akcie:Ordinary Shares
RICEKTAb.ST
ISINSE0000163628
Poslední známé roční výsledky30.04.2026
Poslední známé čtvrtletní výsledky30.04.2026
Počet zaměstnanců k 30.04.2026 4 353
Akcie v oběhu k 30.04.2026 382 083 120
MěnaSEK
Kontaktní informace
UliceBox 7593
MěstoSTOCKHOLM
PSČ103 93
ZeměSweden
Kontatní osobaPeter Nyquist
Funkce kontaktní osobyHead of Investor Relations
Telefon46 858 725 400
Fax46858725500

Business Summary: Elekta AB (publ) is a Sweden-based medical technology company which aims to improve, prolong and save lives through clinical solutions for treating cancer and brain disorders. The Company offers and develops systems for radiation therapy and radio-surgery, as well as software systems that enhance workflow efficiency throughout the entire spectrum of cancer care. Elekta AB (publ) develops clinical treatment solutions for radiation therapy and radiosurgery, as well as work flow-enhancing software systems, across the spectrum of cancer care. The Company provides clinical solutions for image guided radiation therapy and stereotactic radiosurgery, giving oncologists and neurosurgeons an unmatched capability to treat tumors and functional targets with ultra-high precision while sparing healthy tissue.
Financial Summary: BRIEF: For the fiscal year ended 30 April 2026, Elekta AB (publ) revenues decreased 7% to SEK16.72B. Net loss applicable to common stockholders totaled SEK519M vs. income of SEK237M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Net loss reflects R&D expenses -total gross increase from SEK57M to SEK1.87B (expense).
Odvětvová klasifikace
TRBC2009Advanced Medical Equipment
TRBC2012Advanced Medical Equipment & Technology (NEC)
RBSS2004Advanced Medical Equipment
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSElectromedical and Electrotherapeutic Apparatus Manufacturing
NAICSSoftware Publishers
NAICSOther Scientific and Technical Consulting Services
NAICSResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
NAICS2007Electromedical Apparatus Mfg
NAICS2007Software Publishers
NAICS2007Other Scientific and Technical Consulting Services
NAICS2007Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
NAICS2007Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
NAICS2007All Other Miscellaneous Schools & Instruction
NAICS1997Electromedical and Electrotherapeutic Apparatus Manufacturing
NAICS1997Software Publishers
NAICS1997Other Scientific and Technical Consulting Services
NAICS1997Research and Development in the Physical, Engineering, and Life Sciences
NAICS1997Medical, Dental and Hospital Equipment and Supplies Wholesalers
NAICS1997All Other Miscellaneous Schools and Instruction
SICElectromedical Equipment
SICPrepackaged Software
SICServices, Nec
SICCommercial Physical Research



  • Poslední aktualizace: 11.06.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
President, Chief Executive Officer, Member of the Executive CommitteeJakob Just-Bomholt-01.09.202501.09.2025
Chief Financial Officer, Member of the Executive CommitteeKlara Eiritz-
Executive Vice President, Chief People Officer, Member of the Executive CommitteeAnna Lundgren4001.01.2023
Member of the Executive CommitteeJonas Bolander5901.09.202507.07.2015
President - Linac & Software Solutions, Member of the Executive CommitteeChristopher Busch5601.01.2025
President - Brachy & Neuro Solutions, Member of the Executive CommitteeJohn Lapre5930.04.2023
Chief Commercial Officer, Member of the Executive CommitteeHabib Nehme6130.04.2023